Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research

Molecules(2025)10.3390/molecules30112471Source: DataRank Database

N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research is a research paper published in Molecules (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Liang Sun ORCID,Yiran Huang ORCID,Kai Gui ORCID,Karna Terpstra,Liviu M. Mirica ORCID

Live enrichment

PubMed:40509358 PMC:PMC12156033 OpenAlex:https://openalex.org/W4411061612

NIH

Grant: R01GM114588

NIH

Grant: RF1AG083937

NIH

Grant: DGE 21-46756

NIH HHS

Grant: R01GM114588 and RF1AG083937

National Institutes of Health

Grant: 1RF1AG083937-01

Blood-Brain Barrier Permeable Multimodal Imaging Agents for Neurodegenerative Diseases

National Institutes of Health

Grant: 7R01GM114588-05

Novel Bifunctional Chemical Agents as Theranostic Tools for Amyloid Diseases

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://www.mdpi.com/1420-3049/30/11/2471/pdf?version=1749118271

publisherhttps://www.mdpi.com/1420-3049/30/11/2471/pdf?version=1749118271

publisherhttps://www.mdpi.com/1420-3049/30/11/2471/pdf

journalhttps://doi.org/10.3390/molecules30112471

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40509358

Fields of Study

Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery MethodsStilbenesAlzheimer DiseaseAmyloid beta-PeptidesHumansProtein Aggregates

MeSH Terms

Alzheimer DiseaseHumansStilbenesAmyloid beta-PeptidesProtein Aggregates

Keywords

In vivoPeptideAmyloid (mycology)ChemistryIn vitroDiseaseAlzheimer's diseasePopulationSmall moleculeAmyloid βAmyloid precursor proteinAmyloid betaBiochemistryBiophysicsPharmacologyNeuroscienceBiologyMedicinePathologyGeneticsbeta-amyloidProtein aggregationAlzheimer’s diseaseChemical ToolsAβ ProbesAmyloid beta-PeptidesNeuroscience and NeurologyOrganic chemistryMedicine and PharmacologyArticleProtein AggregatesQD241-441Alzheimer DiseaseStilbenesHumans

N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research

FAIR Checklist

Authors (6)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)